Search Results - "Gershon, Anne"

Refine Results
  1. 1

    Clinical Features of Varicella-Zoster Virus Infection by Kennedy, Peter G E, Gershon, Anne A

    Published in Viruses (02-11-2018)
    “…Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in…”
    Get full text
    Journal Article
  2. 2

    Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not Gone by Dooling, Kathleen, Marin, Mona, Gershon, Anne A

    Published in The Journal of infectious diseases (21-10-2022)
    “…After 25 years of varicella vaccination in the United States, classic varicella and its complications have become an uncommon occurrence. The clinical…”
    Get full text
    Journal Article
  3. 3

    Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future? by Gershon, Anne A

    Published in The Journal of infection (01-06-2017)
    “…Summary Varicella and zoster continue to cause significant morbidity and even mortality in children and adults. Complications include bacterial superinfection,…”
    Get full text
    Journal Article
  4. 4

    Pathogenesis and Current Approaches to Control of Varicella-Zoster Virus Infections by GERSHON, Anne A, GERSHON, Michael D

    Published in Clinical Microbiology Reviews (01-10-2013)
    “…Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Varicella Vaccine: What Have You Done for Me Lately? by Gershon, Anne A

    Published in Pediatrics (Evanston) (01-07-2019)
    “…The live attenuated varicella vaccine remains the only vaccine in use against a virus that has a latent form and therefore causes 2 illnesses: varicella and…”
    Get full text
    Journal Article
  6. 6

    Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review by Marin, Mona, Leung, Jessica, Gershon, Anne A

    Published in Pediatrics (Evanston) (01-09-2019)
    “…Live vaccines usually provide robust immunity but can transmit the vaccine virus. To assess the characteristics of secondary transmission of the vaccine-strain…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Tale of two vaccines: differences in response to herpes zoster vaccines by Gershon, Anne A

    Published in The Journal of clinical investigation (01-10-2018)
    “…About one-third of the US population will develop herpes zoster (HZ, commonly known as shingles) over a lifetime, while two-thirds will not. It is not clear…”
    Get full text
    Journal Article
  9. 9

    Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program by Levin, Myron J, Duchon, Jennifer M, Swamy, Geeta K, Gershon, Anne A

    Published in PloS one (03-07-2019)
    “…Despite vaccination, there were more than 100,000 annual cases of varicella in the United States in 2013-2014. Individuals at highest risk of developing severe…”
    Get full text
    Journal Article
  10. 10

    Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster by Gershon, Anne A, Gershon, Michael D, Shapiro, Eugene D

    Published in The Journal of infectious diseases (30-09-2021)
    “…Abstract Michiaki Takahashi developed the live attenuated varicella vaccine in 1974 . This was the first, and is still the only, herpesvirus vaccine. Early…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Varicella zoster vaccines and their implications for development of HSV vaccines by Gershon, Anne A

    Published in Virology (New York, N.Y.) (05-01-2013)
    “…Abstract Live attenuated vaccines to prevent varicella and zoster have been available in the US for the past 17 years, with a resultant dramatic decrease in…”
    Get full text
    Journal Article
  13. 13

    Varicella Vaccine: a Molecular Variant That May Contribute to Attenuation by Gershon, Anne A, Gershon, Michael D

    Published in mBio (20-12-2022)
    “…Varicella was troublesome when varicella vaccine (vOka) was licensed in the United States. Varicella's yearly death toll was ~100, indirect costs were massive,…”
    Get full text
    Journal Article
  14. 14

    Use of Saliva to Identify Varicella Zoster Virus Infection of the Gut by Gershon, Anne A., Chen, Jason, Gershon, Michael D.

    Published in Clinical infectious diseases (15-08-2015)
    “…Background. Varicella zoster virus (VZV) establishes latency in dorsal root, cranial nerve, and enteric ganglia and can reactivate to cause zoster. Serious…”
    Get full text
    Journal Article
  15. 15

    Herpes zoster vaccine live: A 10 year review of post-marketing safety experience by Willis, English D., Woodward, Meredith, Brown, Elizabeth, Popmihajlov, Zoran, Saddier, Patricia, Annunziato, Paula W., Halsey, Neal A., Gershon, Anne A.

    Published in Vaccine (19-12-2017)
    “…•After 10 years of post-marketing use, safety of zoster vaccine live remains favorable.•93% of reports of adverse experiences were non-serious.•Injection-site…”
    Get full text
    Journal Article
  16. 16

    Varicella vaccination - the global experience by Wutzler, Peter, Bonanni, Paolo, Burgess, Margaret, Gershon, Anne, Sáfadi, Marco Aurélio, Casabona, Giacomo

    Published in Expert review of vaccines (03-08-2017)
    “…Varicella, although a frequently benign childhood disease, nevertheless represents a considerable health burden. WHO recommends including varicella vaccines in…”
    Get full text
    Journal Article
  17. 17

    Shingles vaccine after auto-HSCT decreases risk by Macartney, Kristine, Gershon, Anne A

    Published in The Lancet (British edition) (26-05-2018)
    “…The risk of developing herpes zoster seems to be highest in the early stages after transplantation, but viral reactivation can still occur over 5 years after…”
    Get full text
    Journal Article
  18. 18

    Varicella zoster virus infection by Gershon, Anne A., Breuer, Judith, Cohen, Jeffrey I., Cohrs, Randall J., Gershon, Michael D., Gilden, Don, Grose, Charles, Hambleton, Sophie, Kennedy, Peter G. E., Oxman, Michael N., Seward, Jane F., Yamanishi, Koichi

    Published in Nature reviews. Disease primers (02-07-2015)
    “…Infection with varicella zoster virus (VZV) causes varicella (chickenpox), which can be severe in immunocompromised individuals, infants and adults. Primary…”
    Get full text
    Journal Article
  19. 19

    Freedom, Measles, and Freedom from Measles by Gershon, Anne A, Edwards, Kathryn, Orenstein, Walter, Schaffner, William

    Published in The New England journal of medicine (12-03-2020)
    “…False rumors about purported dangers of vaccination continue to circulate. People who reject the scientific facts about vaccines and pathogens in favor of an…”
    Get full text
    Journal Article
  20. 20

    The Safety Profile of Varicella Vaccine: A 10-Year Review by Galea, Susan A., Sweet, Ann, Beninger, Paul, Steinberg, Sharon P., LaRussa, Philip S., Gershon, Anne A., Sharrar, Robert G.

    Published in The Journal of infectious diseases (01-03-2008)
    “…Varivax (varicella virus vaccine live [Oka/Merck]; Merck), a live attenuated varicella vaccine, is indicated for vaccination against varicella in appropriate…”
    Get full text
    Journal Article